BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Cardiol. Jul 26, 2026; 18(7): 121228
Published online Jul 26, 2026. doi: 10.4330/wjc.121228
Table 1 Baseline demographic, clinical, and echocardiographic characteristics of the study cohort (n = 28)
Variable
Total (n = 28)
Survivors (n = 24)
Non-survivors (n = 4)
P value
Age (years)73.82 ± 12.1474.12 ± 11.6872.00 ± 16.570.819
Male sex, %61.964.750.00.618
Smoking, %21.420.825.01.000
Hypertension, %100.0100.0100.01.000
Dyslipidemia, %96.4100.075.00.143
Obesity, %29.630.425.01.000
Diabetes mellitus, %53.650.075.00.600
Valvular heart disease, %71.475.050.00.555
Systolic BP (mmHg)173.39 ± 38.52172.58 ± 39.94178.25 ± 33.050.772
Diastolic BP (mmHg)99.39 ± 21.2399.75 ± 22.5997.25 ± 11.700.746
Heart rate (bpm)105.61 ± 23.04105.75 ± 24.69104.75 ± 10.240.892
NT-proBNP (pg/mL)10513.96 ± 10381.239955.83 ± 10293.2713862.75 ± 11840.240.569
TAPSE (mm)22.61 ± 8.2023.29 ± 8.6118.50 ± 3.320.072
LVOT VTI (cm)16.20 ± 4.5216.03 ± 4.7217.23 ± 3.340.561
RV-RA gradient (mmHg)28.93 ± 9.7429.00 ± 10.5128.50 ± 2.650.845
LVEF (%)38.68 ± 15.4238.83 ± 15.0737.75 ± 19.920.923


Write to the Help Desk